C. Lepage, L. Dahan, J.-L. Legoux, K. Le Malicot, R. Guimbaud, et al.. REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors .
The 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. Neuroendocrinology, 105 (Suppl. 1), pp.187 (J8), 2017,
〈https://www.karger.com/Article/Pdf/484263〉.
〈hal-01664217〉 
